Original Query: ALL
Previous Study | Return to List | Next Study

Ranibizumab "Treat and Extend" in Diabetic Macular Edma (OPTIMAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01297569
Recruitment Status : Completed
First Posted : February 16, 2011
Last Update Posted : February 23, 2017
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2012
  Study Completion Date : November 2012